lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Development of a Deep Learning Model for T1N0 Gastric Cancer Diagnosis Using 2.5D Radiomic Data in Preoperative CT Images

21 Pages Posted: 17 Dec 2024

See all articles by Jingli Xu

Jingli Xu

Zhejiang Cancer Hospital

Jingyang He

Zhejiang Cancer Hospital

Wujie Chen

Zhejiang Cancer Hospital

Mengxuan Cao

Zhejiang Cancer Hospital

Jiaqing Zhang

Zhejiang Cancer Hospital

Qing Yang

Zhejiang Cancer Hospital

Enze Li

Zhejiang Cancer Hospital

Ruolan Zhang

Zhejiang Cancer Hospital

Yahan Tong

Zhejiang Cancer Hospital

Yanqiang Zhang

Zhejiang Cancer Hospital

Chen Gao

Chinese Academy of Sciences (CAS)

Qianyu Zhao

Zhejiang Cancer Hospital

Zhi-Yuan Xu

Chinese Academy of Sciences (CAS) - Cancer Hospital; Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)

Lijing Wang

Zhejiang Cancer Hospital

Xiangdong Cheng

Chinese Academy of Sciences (CAS) - Institute of Basic Medicine and Cancer (IBMC)

GuoLiang Zheng

Dalian University of Technology - Liaoning Cancer Institute and Hospital

Siwei Pan

Zhejiang Cancer Hospital

Can Hu

Zhejiang Cancer Hospital

More...

Abstract

Background: Early detection and precise preoperative staging of early gastric cancer (EGC) are critical, this study aims to develop a deep learning model using portal venous phase CT images to accurately distinguish EGC without lymph node metastasis (LNM).


Methods: This study included 3164 patients with gastric cancer (GC) who underwent radical surgery at two medical centers in China from 2006 to 2019. 2.5D radiomic data and multi instance learning (MIL) were novel approaches applied in this study. The features selected from MIL were then apply to six machine learning models to build a pT1N0 predicting model. Area under the curve (AUC) of the receiver operator characteristic (ROC) curves and decision curve analysis (DCA) were used to evaluate the diagnostic effectiveness and the clinical utility.

Findings: Basing 2.5D radiomic data and MIL to select features, the ResNet101 model combined with the XGBoost model represented a satisfactory performance for diagnosing pT1N0 GC with AUC of 0.920 (95% CI: 0.907-0.933), 0.774 (95% CI: 0.738-0.810) and 0.744 (95% CI: 0.686-0.803) in the training, internal and external validation cohorts, respectively. Furthermore, the training cohort had an accuracy of 86.3%, a sensitivity of 84.9%, and a specificity of 89.6%, the internal validation cohort had an accuracy of 76.7%, a sensitivity of 76.5%, and a specificity of 77.4%, meanwhile, the external validation cohort had an accuracy of 74.9%, a sensitivity of 72.0%, and a specificity of 83.7%. The 2.5D MIL-based model demonstrated a markedly superior predictive performance compared to traditional radiomics models and clinical models.

Interpretation: We firstly constructed a deep learning prediction model based on 2.5D radiomics and MIL for effectively diagnosing pT1N0 GC patients, which provides valuable information for the individualized treatment selection.

Funding: This study was supported by The National Key Research and Development Program of China (2021YFA0910100), Healthy Zhejiang One Million People Cohort (K-20230085), Post-doctoral Innovative Talent Support Program (BX2023375), National Natural Science Foundation of China (82304946, 82473489, 82403546), Natural Science Foundation of Zhejiang Province (LR21H280001, MS25H160146, TGY23H160038), and The Medicine and Health Science Fund of Zhejiang Province (2025KY047, 2023KY073).

Declaration of Interest: All coauthors report no conflict of interest.

Ethical Approval:  The study has been approved by the Ethics Committees of all participating centers (IRB-2024- 220).

Keywords: Early gastric cancer, Lymph node metastasis, Deep Learning, Multi instance learning, Radiomics

Suggested Citation

Xu, Jingli and He, Jingyang and Chen, Wujie and Cao, Mengxuan and Zhang, Jiaqing and Yang, Qing and Li, Enze and Zhang, Ruolan and Tong, Yahan and Zhang, Yanqiang and Gao, Chen and Zhao, Qianyu and Xu, Zhi-Yuan and Wang, Lijing and Cheng, Xiangdong and Zheng, GuoLiang and Pan, Siwei and Hu, Can, Development of a Deep Learning Model for T1N0 Gastric Cancer Diagnosis Using 2.5D Radiomic Data in Preoperative CT Images. Available at SSRN: https://ssrn.com/abstract=5058474 or http://dx.doi.org/10.2139/ssrn.5058474

Jingli Xu

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Jingyang He

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Wujie Chen

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Mengxuan Cao

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Jiaqing Zhang

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Qing Yang

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Enze Li

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Ruolan Zhang

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Yahan Tong

Zhejiang Cancer Hospital ( email )

Yanqiang Zhang

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Chen Gao

Chinese Academy of Sciences (CAS) ( email )

Qianyu Zhao

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Zhi-Yuan Xu

Chinese Academy of Sciences (CAS) - Cancer Hospital ( email )

Hangzhou, 310022
China

Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) ( email )

China

Lijing Wang

Zhejiang Cancer Hospital ( email )

Xiangdong Cheng

Chinese Academy of Sciences (CAS) - Institute of Basic Medicine and Cancer (IBMC) ( email )

GuoLiang Zheng

Dalian University of Technology - Liaoning Cancer Institute and Hospital ( email )

China

Siwei Pan

Zhejiang Cancer Hospital ( email )

Zhejiang
China

Can Hu (Contact Author)

Zhejiang Cancer Hospital ( email )

Zhejiang
China